Effect of ATP on smooth muscle of toad urinary bladder.
Adenosine 5'-triphosphate (ATP), at a dose range of 1.8 to 116 microM, produced an initial phasic contraction followed by a rhythmic contraction in urinary bladder smooth muscle of the toad (Bufo melanostictus). Acetylcholine produced a rhythmic contraction which was antagonized by atropine (1.5 microM) and potentiated by neostigmine (1.7 microM), indicating activation of muscarinic receptors. However, both phasic and rhythmic components of ATP contraction were atropine-resistant. Quinidine (26-264 M) abolished the responses to ATP and acetylcholine, while indomethacin (28 microM) and theophylline (55 microM) antagonized only the acetylcholine responses. Repeated application of alpha, beta-methylene ATP desensitized the receptors and completely abolished contraction. ATP did not produce a phasic contraction in alpha, beta-methylene ATP-desensitized tissue, indicating that both ATP and its alpha, beta-methylene analogue occupy the same receptor site for phasic contraction. On the other hand, the rhythmic contraction induced by ATP remained unaffected in alpha, beta-methylene ATP-treated tissue. The phasic contraction in response to ATP can be blocked by verapamil (4 microM), but rhythmic contraction can only be abolished by a high concentration of verapamil (16 microM). Moreover, ATP produced no response in Ca+(+)-free or EGTA-containing solution, showing thereby that contractile responses to ATP are dependent upon extracellular Ca(+)+. These results indicate that the phasic component is a P2x-receptor-activated response while the rhythmic component might be an opening of calcium ion channels, either by depolarization of the membrane or by some unknown mechanism.
Saha
J K
JK
Department of Physiology, University College of Science, University of Calcutta, India.
Sengupta
J N
JN
Koley
B N
BN
Koley
J
J
D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002025:Bufonidae; D002121:Calcium Channel Blockers / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D009388:Neostigmine / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D001743:Urinary Bladder / Q000187:drug effects
D002121:Calcium Channel Blockers; D009388:Neostigmine; D004533:Egtazic Acid; D001285:Atropine; D000255:Adenosine Triphosphate; D013806:Theophylline; D011802:Quinidine; D000109:Acetylcholine; C002630:alpha,beta-methyleneadenosine 5'-triphosphate; D007213:Indomethacin